BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 10999117)

  • 1. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
    Poungvarin N; Viriyavejakul A
    J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
    Greene PE; Fahn S
    Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin in the treatment of dystonic tics.
    Jankovic J
    Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
    Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
    Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin.
    Metzer WS; Jenkins T
    J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
    Comella CL; Shannon KM; Jaglin J
    Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of Botox and a Chinese type a botulinum toxin in cervical dystonia].
    Wan X; Tang X
    Zhonghua Yi Xue Za Zhi; 1998 Feb; 78(2):131-4. PubMed ID: 10923426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
    Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.
    Quagliato EM; Carelli EF; Viana MA
    Clin Neuropharmacol; 2010; 33(1):22-6. PubMed ID: 19959960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of spasmodic torticollis by local injections of botulinum toxin].
    Jedynak CP; de Saint Victor JF
    Rev Neurol (Paris); 1990; 146(6-7):440-3. PubMed ID: 2399409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.